Back to search
FDAFDA · Food and drugs·Recall number D-0638-2026

Med Pride, 1% Clotrimazole Antifungal Cream, Net Wt. 1oz (28.3g), Manufactured for: Shield Line LLC, 59 Hook Road, Bayonne, NJ 07002 USA, Made in India, UPC 3 524103 0244 2.

Published June 24, 2026 · Recall initiated: June 2, 2026

Summary

FDA records drug Class II recall D-0638-2026, published June 24, 2026 and initiated June 2, 2026. Recalling firm: Dabur India Limited; Status: Ongoing; Reported quantity: 5755 tubes; Lot: Lot# 001, 002, 003, 004, 005, 006, 007, 008, 009, 010, 011, 012, 013, Within Expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations; deficiencies observed during FDA inspection

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Dabur India Limited
Distributor
US Nationwide.
Lot
Lot# 001, 002, 003, 004, 005, 006, 007, 008, 009, 010, 011, 012, 013, Within Expiry.
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Med Pride, 1% Clotrimazole Antifungal Cream, Net Wt. 1oz (28.3g), Manufactured for: Shield Line LLC, 59 Hook Road, Bayonne, NJ 07002 USA, Made in India, UPC 3 524103 0244 2. recalled?

Yes. FDA published recall D-0638-2026 on June 24, 2026. Reported hazard: CGMP Deviations; deficiencies observed during FDA inspection

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail